Drugs / Amoxicillin/clavulanate
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06076304 Comparator | Nov 2023 → Oct 2028 expected | sinusitis | Daniel Merenstein | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Amoxicillin/clavulanate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06076304 ↗ |
| Route | Oral | “Amoxicillin/clavulanate, oral, 875mg/125mg twice daily for 7 days” NCT06076304 ↗ |